Nova MSC subsidiary EyRIS wins RM7.13M contract for Brunei diabetic retinopathy screening

EyRIS Pte Ltd, a subsidiary of Nova MSC Berhad, secured a RM7.13 million contract from JPMCnova Sdn Bhd to launch a national diabetic retinopathy screening program in Brunei using AI platform SELENA+, starting October 2024.

“Kami berbangga dapat bekerjasama dengan KKM, Brunei dalam usaha mereka untuk memanfaatkan teknologi AI untuk mengubah cara perkhidmatan perubatan boleh disampaikan secara kos efektif.”dagangnews.com

• 1 source
• dagangnews.comNova MSC peroleh kontrak RM7.13 juta laksanakan program saringan Retinopati Diabetik Kebangsaan di Brunei | DagangNews - Berita Bisnes AndaSep 9, 2024

Summarized from public sources; check the original articles before acting on it.